BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 36042526)

  • 1. The lipid rafts in cancer stem cell: a target to eradicate cancer.
    Zhang S; Zhu N; Li HF; Gu J; Zhang CJ; Liao DF; Qin L
    Stem Cell Res Ther; 2022 Aug; 13(1):432. PubMed ID: 36042526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer stem cells.
    Yu Z; Pestell TG; Lisanti MP; Pestell RG
    Int J Biochem Cell Biol; 2012 Dec; 44(12):2144-51. PubMed ID: 22981632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid rafts as signaling hubs in cancer cell survival/death and invasion: implications in tumor progression and therapy: Thematic Review Series: Biology of Lipid Rafts.
    Mollinedo F; Gajate C
    J Lipid Res; 2020 May; 61(5):611-635. PubMed ID: 33715811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in Therapeutic Targeting of Cancer Stem Cells within the Tumor Microenvironment: An Updated Review.
    Dzobo K; Senthebane DA; Ganz C; Thomford NE; Wonkam A; Dandara C
    Cells; 2020 Aug; 9(8):. PubMed ID: 32823711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Motility and stem cell properties induced by the epithelial-mesenchymal transition require destabilization of lipid rafts.
    Tisza MJ; Zhao W; Fuentes JS; Prijic S; Chen X; Levental I; Chang JT
    Oncotarget; 2016 Aug; 7(32):51553-51568. PubMed ID: 27303921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer Stem Cells: Acquisition, Characteristics, Therapeutic Implications, Targeting Strategies and Future Prospects.
    Yadav AK; Desai NS
    Stem Cell Rev Rep; 2019 Jun; 15(3):331-355. PubMed ID: 30993589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rafting Down the Metastatic Cascade: The Role of Lipid Rafts in Cancer Metastasis, Cell Death, and Clinical Outcomes.
    Greenlee JD; Subramanian T; Liu K; King MR
    Cancer Res; 2021 Jan; 81(1):5-17. PubMed ID: 32999001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer stem cells (CSCs) in cancer progression and therapy.
    Najafi M; Farhood B; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of the putative CD44+CD24- breast cancer stem cell population by targeting the polyamine metabolic pathway with PG11047.
    Cirenajwis H; Smiljanic S; Honeth G; Hegardt C; Marton LJ; Oredsson SM
    Anticancer Drugs; 2010 Nov; 21(10):897-906. PubMed ID: 20838207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid raft-disrupting miltefosine preferentially induces the death of colorectal cancer stem-like cells.
    Park SY; Kim JH; Choi JH; Lee CJ; Lee WJ; Park S; Park ZY; Baek JH; Nam JS
    Clin Transl Med; 2021 Nov; 11(11):e552. PubMed ID: 34841679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholesterol and Sphingolipid Enriched Lipid Rafts as Therapeutic Targets in Cancer.
    Codini M; Garcia-Gil M; Albi E
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33450869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of microRNAs in the regulation of breast cancer stem cells.
    Liu S; Clouthier SG; Wicha MS
    J Mammary Gland Biol Neoplasia; 2012 Mar; 17(1):15-21. PubMed ID: 22331423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of Lipid Raft Proteins from CD133+ Cancer Stem Cells.
    Gupta VK; Banerjee S
    Methods Mol Biol; 2017; 1609():25-31. PubMed ID: 28660570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem cell programs in cancer initiation, progression, and therapy resistance.
    Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
    Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation and signaling pathways in cancer stem cells: implications for targeted therapy for cancer.
    Zeng Z; Fu M; Hu Y; Wei Y; Wei X; Luo M
    Mol Cancer; 2023 Oct; 22(1):172. PubMed ID: 37853437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid raft involvement in signal transduction in cancer cell survival, cell death and metastasis.
    Li B; Qin Y; Yu X; Xu X; Yu W
    Cell Prolif; 2022 Jan; 55(1):e13167. PubMed ID: 34939255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
    Yan Y; Zuo X; Wei D
    Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fascin Is Critical for the Maintenance of Breast Cancer Stem Cell Pool Predominantly via the Activation of the Notch Self-Renewal Pathway.
    Barnawi R; Al-Khaldi S; Majed Sleiman G; Sarkar A; Al-Dhfyan A; Al-Mohanna F; Ghebeh H; Al-Alwan M
    Stem Cells; 2016 Dec; 34(12):2799-2813. PubMed ID: 27502039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid rafts as major platforms for signaling regulation in cancer.
    Mollinedo F; Gajate C
    Adv Biol Regul; 2015 Jan; 57():130-46. PubMed ID: 25465296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug Resistance Driven by Cancer Stem Cells and Their Niche.
    Prieto-Vila M; Takahashi RU; Usuba W; Kohama I; Ochiya T
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29194401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.